newsfilter
← Latest News
GlobeNewswire·

Hillstream BioPharma Provides Corporate Update

Recent milestones include FDA Orphan Drug Designations for HSB-1216 and HSB-888 World-class scientific advisory team and growing and distinguished patent portfolio remain key competitive advantages Company ended Q1 2022 with $11 million in cash Pr